One study by Carola Torazza and her team at the University of Genoa has shed light on a promising avenue for treating Amyotrophic Lateral Sclerosis (ALS) by targeting a specific receptor in , known as metabotropic glutamate receptor type 5 (mGluR5). Published on July 27, 2023, in the journal …
A study by Aradhana Sachdev and colleagues, published on April 23, 2024, in the Proceedings of the National Academy of Sciences of the United States of America, sheds light on potential genetic interventions for conditions linked to the C9orf72 , a major contributor to amyotrophic lateral sclerosis (ALS) …
A study by Shravan Gowrishankar and colleagues, published in PloS One in 2024, has provided valuable insights into the use of immunosuppression in stem clinical trials, particularly for conditions like amyotrophic lateral sclerosis (ALS). Conducted by researchers from the Department of ENT at Cambridge University Hospitals in the United …
One study by Ton Fang and colleagues from King's College London has provided valuable insights into how the medication riluzole affects survival in patients with amyotrophic lateral sclerosis (ALS). Published in The Lancet Neurology in May 2018, this research analyzed data from a previous clinical trial to determine at which …
A study by Francis R. Willett and colleagues, published in August 2023 in the journal Nature, explores a groundbreaking speech neuroprosthesis that could significantly enhance communication for individuals with amyotrophic lateral sclerosis (ALS) and other conditions that impair speech. Conducted at the Howard Hughes Medical Institute at Stanford University, …
A study published in Scientific Reports on May 18, 2024, by Zhao Li and colleagues from the College of Sport Science at Sungkyunkwan University, has shed light on the effectiveness of various non-drug treatments for individuals living with amyotrophic lateral sclerosis (ALS). This systematic review and network meta-analysis examined five …